Paul B Fitzgerald1, Kate E Hoy2, David Elliot2, Susan McQueen2, Lenore E Wambeek2, Zafiris J Daskalakis3. 1. Monash Alfred Psychiatry Research Centre, The Alfred and Monash University Central Clinical School, St Kilda Road, Melbourne, Victoria 3004, Australia. Electronic address: paul.fitzgerald@monash.edu. 2. Monash Alfred Psychiatry Research Centre, The Alfred and Monash University Central Clinical School, St Kilda Road, Melbourne, Victoria 3004, Australia. 3. Temerty Centre for Therapeutic Brain Intervention and the Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada.
Abstract
BACKGROUND/ OBJECTIVE: To explore the therapeutic benefit of sequential bilateral repetitive transcranial magnetic stimulation (rTMS) in the treatment of bipolar depression. METHOD: A 2 arm randomized controlled parallel design trial comparing the use of active sequential bilateral rTMS to a sham form of stimulation in 49 patients with bipolar disorder and treatment resistant depression. RESULTS: There was no significant difference in mean reduction in depression rating scale scores or response rates between active and sham stimulation. LIMITATIONS: The study was of limited sample size and the use of bilateral rTMS limited generalizability to other forms of rTMS. CONCLUSIONS: This study provides no support to the use of active sequential bilateral rTMS in the treatment of the depressive phase of bipolar affective disorder. Although this result is not definitive, we suggest that future research may be better focused on trials evaluating the use of unilateral types of rTMS.
RCT Entities:
BACKGROUND/ OBJECTIVE: To explore the therapeutic benefit of sequential bilateral repetitive transcranial magnetic stimulation (rTMS) in the treatment of bipolar depression. METHOD: A 2 arm randomized controlled parallel design trial comparing the use of active sequential bilateral rTMS to a sham form of stimulation in 49 patients with bipolar disorder and treatment resistant depression. RESULTS: There was no significant difference in mean reduction in depression rating scale scores or response rates between active and sham stimulation. LIMITATIONS: The study was of limited sample size and the use of bilateral rTMS limited generalizability to other forms of rTMS. CONCLUSIONS: This study provides no support to the use of active sequential bilateral rTMS in the treatment of the depressive phase of bipolar affective disorder. Although this result is not definitive, we suggest that future research may be better focused on trials evaluating the use of unilateral types of rTMS.
Authors: Diego F Tavares; Martin L Myczkowski; Rodrigo L Alberto; Leandro Valiengo; Rosa M Rios; Pedro Gordon; Bernardo de Sampaio-Junior; Izio Klein; Carlos G Mansur; Marco Antonio Marcolin; Beny Lafer; Ricardo A Moreno; Wagner Gattaz; Zafiris J Daskalakis; André R Brunoni Journal: Neuropsychopharmacology Date: 2017-02-01 Impact factor: 7.853
Authors: Chris Baeken; Anna-Katharine Brem; Martijn Arns; Andre R Brunoni; Igor Filipčić; Ana Ganho-Ávila; Berthold Langguth; Frank Padberg; Emmanuel Poulet; Fady Rachid; Alexander T Sack; Marie-Anne Vanderhasselt; Djamila Bennabi Journal: Curr Opin Psychiatry Date: 2019-09 Impact factor: 4.741
Authors: Alexandra K Gold; Ana Claudia Ornelas; Patricia Cirillo; Marco Antonio Caldieraro; Antonio Egidio Nardi; Andrew A Nierenberg; Gustavo Kinrys Journal: Brain Behav Date: 2019-09-30 Impact factor: 2.708
Authors: Konstantinos N Fountoulakis; Lakshmi N Yatham; Heinz Grunze; Eduard Vieta; Allan H Young; Pierre Blier; Mauricio Tohen; Siegfried Kasper; Hans Jurgen Moeller Journal: Int J Neuropsychopharmacol Date: 2020-04-23 Impact factor: 5.176